Eva H.C. Tang
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology 9
- Physiology top 2%
- Nitric Oxide and Endothelin Effects 12
-
- Blood Pressure and Hypertension Studies 1
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 9
-
- Hormonal Regulation and Hypertension 3
-
- Inflammatory mediators and NSAID effects 7
-
- Chemokine receptors and signaling 3
-
- Receptor Mechanisms and Signaling 2
- Redox biology and oxidative stress 2
- Co-authors
- Paul M. VanhoutteMichel FélétouHiroaki ShimokawaRicky Y.K. ManYü HuangAimin XuPeter LibbyF Leung
- Journals
- The Journal of Physiology (1 paper)The FASEB Journal (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (2 papers)
- Partner nations
- Hong KongUnited StatesFrance
In The Last Decade
Eva H.C. Tang
19 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Biochemistry 524
- Physiology 1.0k
- Cardiology and Cardiovascular Medicine 752
- Biochemistry 128
- Endocrinology, Diabetes and Metabolism 343
Countries citing papers authored by Eva H.C. Tang
This map shows the geographic impact of Eva H.C. Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva H.C. Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva H.C. Tang more than expected).
Fields of papers citing papers by Eva H.C. Tang
This network shows the impact of papers produced by Eva H.C. Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva H.C. Tang. The network helps show where Eva H.C. Tang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eva H.C. Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 11 | |
| 2 | Endothelial dysfunction and vascular disease - a 30th anniversary updatebreakdown → | 2015 | 667 |
| 3 | 2015 | 20 | |
| 4 | 2014 | 25 | |
| 5 | 2014 | 33 | |
| 6 | 2014 | 27 | |
| 7 | 2011 | 69 | |
| 8 | 2010 | 56 | |
| 9 | 2010 | 40 | |
| 10 | 2010 | 142 | |
| 11 | 2009 | 90 | |
| 12 | Endothelial dysfunction and vascular diseasebreakdown → | 2009 | 637 |
| 13 | 2008 | 134 | |
| 14 | 2008 | 32 | |
| 15 | 2007 | 110 | |
| 16 | 2007 | 58 | |
| 17 | 2007 | 138 | |
| 18 | 2005 | 88 | |
| 19 | 2005 | 59 |
About Eva H.C. Tang
Eva H.C. Tang is a scholar working on Biochemistry, Physiology and Pharmacology, having authored 19 papers that have together received 2.4k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (12 papers), Eicosanoids and Hypertension Pharmacology (9 papers), Inflammatory mediators and NSAID effects (7 papers), Chemokine receptors and signaling (3 papers), Hormonal Regulation and Hypertension (3 papers), Receptor Mechanisms and Signaling (2 papers), Redox biology and oxidative stress (2 papers) and Blood Pressure and Hypertension Studies (1 paper). The work is most often cited by research in Biochemistry (524 citations), Physiology (1.0k citations) and Cardiology and Cardiovascular Medicine (752 citations). Eva H.C. Tang has collaborated with scholars based in Hong Kong, United States and France. Frequent co-authors include Paul M. Vanhoutte, Michel Félétou, Hiroaki Shimokawa, Ricky Y.K. Man, Paul M. Vanhoutte, Yü Huang, Aimin Xu, Peter Libby, F Leung and Kwok‐Fai So. Their work appears in journals such as The Journal of Physiology, The FASEB Journal and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.